Alpha 2.0
Login Register
» Authors » Jorge Daruich

Jorge Daruich

Explore the profile of Jorge Daruich including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 100
Followers 0
Related Specialties
Gastroenterology
General Medicine
Pharmacology
Top 10 Co-Authors
Esteban Gonzalez Ballerga
Adrian Gadano
Fernando Bessone
Juan Antonio Sorda
Hugo Cheinquer
Eduardo Fassio
Fernando Brites
Raymundo Parana
Jorge Rey
Tomas Merono
Published In
Acta Gastroenterol Latinoam
Ann Hepatol
PLoS One
Aliment Pharmacol Ther
Medicina (B Aires)
Affiliations
Soon will be listed here.
Recent Articles
11.
Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload
Merono T, Brites F, Dauteuille C, Lhomme M, Menafra M, Arteaga A, et al.
Clin Sci (Lond) . 2014 Dec; 128(9):609-18. PMID: 25442240
Iron overload (IO) has been associated with glucose metabolism alterations and increased risk of cardiovascular disease (CVD). Primary IO is associated with mutations in the HFE gene. To which extent...
12.
Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma
Mendez-Sanchez N, Ridruejo E, de Mattos A, Chavez-Tapia N, Zapata R, Parana R, et al.
Ann Hepatol . 2014 Jul; 13 Suppl 1:S4-40. PMID: 24998696
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the third most common cause of cancer death, and accounts for 5.6% of all cancers. Nearly 82%...
13.
An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver
Chavez-Tapia N, Ridruejo E, de Mattos A, Bessone F, Daruich J, Sanchez-Avila J, et al.
Ann Hepatol . 2013 Apr; 12 Suppl 2:s3-35. PMID: 23559487
Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes...
14.
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B
Piratvisuth T, Komolmit P, Tanwandee T, Sukeepaisarnjaroen W, Chan H, Pessoa M, et al.
PLoS One . 2013 Feb; 8(2):e54279. PMID: 23390496
Background And Aims: The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. The efficacy and safety...
15.
[Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection]
Silva M, Ridruejo E, Galdame O, Bessone F, Colombato L, Daruich J, et al.
Acta Gastroenterol Latinoam . 2012 Dec; 42(3):234-49. PMID: 23214356
No abstract available.
16.
[Latin American guideline for the management of chronic hepatitis B]
Gadano A, Daruich J, Cheinquer H, Faimboin H, Pessoa M, Tanno H, et al.
Acta Gastroenterol Latinoam . 2012 Feb; 41(4):340-50. PMID: 22292234
No abstract available.
17.
Chronic hepatitis C treatment in näive patients
Daruich J
Ann Hepatol . 2010 Aug; 9 Suppl:65-71. PMID: 20713999
Hepatitis C (HCV) is a major public health problem worldwide and it is considered that there are about 180 millions of infected people. The natural history of hepatitis C shows...
18.
[Side effects of therapy and management]
Ciocca M, Daruich J, Fernandez N
Acta Gastroenterol Latinoam . 2010 Mar; 35 Suppl 1:S59-62. PMID: 20214307
No abstract available.
19.
[Latin American guideline for the treatment of chronic hepatitis B]
Daruich J, Gadano A, Fainboim H, Pessoa M, Cheinquer H
Acta Gastroenterol Latinoam . 2007 Oct; 37(3):168-77. PMID: 17955728
No abstract available.
20.
[Primer treatment of acute and chronic hepatitis C]
Daruich J, Fainboim H, Frider B
Acta Gastroenterol Latinoam . 2006 Jul; 36 Suppl 1:S52-6. PMID: 16862862
No abstract available.